Use of Direct Oral Anticoagulants in Patients With Peripheral Artery Disease: A Meta-Analysis

Authors

Asmaa Ahmed, Rochester Regional HealthFollow
Mohamed Hamed, Division of Cardiology, Florida Atlantic University, Boca Raton, Florida.
Ahmed Abozaid, Division of Cardiology, Ain Shams University, Cairo, Egypt.
Ahmed Elkheshen, Department of Internal Medicine, Texas Tech University Health, Lubbock, Texas.
Mark Fisher, Division of Cardiology, Florida Atlantic University, Boca Raton, Florida.
Wissam Khalife, Division of Cardiology, University of Texas Medical Branch, Galveston, Texas.
Hani Jneid, Division of Cardiology, University of Texas Medical Branch, Galveston, Texas.
Subhash Banerjee, Division of Cardiology, Baylor University, Dallas, Texas.
Ayman Elbadawi, Division of Cardiology, Christus Good Shepherd Medical Center, Longview, Texas; Texas A&M School of Medicine, Bryan, Texas.

Department

Internal Medicine

Document Type

Article

Publication Title

The American Journal of Cardiology

First Page

34

Last Page

35

DOI

10.1016/j.amjcard.2024.06.031

Volume

226

Publication Date

9-1-2024

Medical Subject Headings

Humans; Peripheral Arterial Disease (drug therapy, complications); Anticoagulants (therapeutic use, administration & dosage); Administration, Oral; Factor Xa Inhibitors (therapeutic use)

PubMed ID

38968978

Recommended Citation

Ahmed, A., Hamed, M., Abozaid, A., Elkheshen, A., Fisher, M., Khalife, W., Jneid, H., Banerjee, S., & Elbadawi, A. (2024). Use of Direct Oral Anticoagulants in Patients With Peripheral Artery Disease: A Meta-Analysis. The American Journal of Cardiology, 226, 34-35. https://doi.org/10.1016/j.amjcard.2024.06.031